Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thyroid-related adverse events induced by immune checkpoint inhibitors
Alexandra Chera, Andreea Lucia Stancu, Octavian Bucur
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Immune-related adverse events of immune checkpoint inhibitors: a review
Qinan Yin, Liuyun Wu, Lizhu Han, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 139
The role of PD-1 signaling in health and immune-related diseases
Ruyue Chen, Yun Zhu, Yunyan Shen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Toxicity in the era of immune checkpoint inhibitor therapy
Synat Keam, Naimah Turner, Fernanda G. Kugeratski, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Thyroid disorders induced by immune checkpoint inhibitors
Dimitra Karaviti, Eleni-Rafaela Kani, Eleftheria Karaviti, et al.
Endocrine (2024) Vol. 85, Iss. 1, pp. 67-79
Open Access | Times Cited: 11
An individualized protein-based prognostic model to stratify pediatric patients with papillary thyroid carcinoma
Zhihong Wang, He Wang, Yan Zhou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma
Thomas M. Kuczmarski, Ryan C. Lynch
British Journal of Haematology (2024) Vol. 205, Iss. 1, pp. 100-108
Closed Access | Times Cited: 4
Pembrolizumab-Mediated Complete Remission of a PLA2R-Positive Paraneoplastic Membranous Nephropathy: A Case Report
Rayane Benyahia, Magali Colombat, Sérigne Maguèye Gueye, et al.
Kidney Medicine (2025) Vol. 7, Iss. 4, pp. 100967-100967
Open Access
Research Progress on Adverse Events of Immune Checkpoint Inhibitors
洪益 肖
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 1493-1500
Closed Access
Life-Threatening Endocrinological Immune-Related Adverse Events of Immune Checkpoint Inhibitor Therapy
Aleksandra Basek, Grzegorz K. Jakubiak, Grzegorz Cieślar, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5786-5786
Open Access | Times Cited: 10
Immune-Related Toxicity in NSCLC: Current State-of-the-Art and Emerging Clinical Challenges
Claire E. T. O'Leary, Nicole Pierce, Sandip Pravin Patel, et al.
Journal of Thoracic Oncology (2023) Vol. 19, Iss. 3, pp. 395-408
Open Access | Times Cited: 9
Incidence of thyroid dysfunction caused by immune checkpoint inhibitors combined with chemotherapy: A systematic review and meta-analysis
Ping Yang, Guoshuang Shen, Hengheng Zhang, et al.
International Immunopharmacology (2024) Vol. 133, pp. 111961-111961
Closed Access | Times Cited: 2
Research hot spots and trends in endocrine-related adverse events caused by immune checkpoint inhibitors: a bibliometric analysis and visualization research
Jun Zhao, Guangwei Liu, Xue Yang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy
Qian Wang, Tingting Wu, Ru Zhao, et al.
Endocrine Practice (2024) Vol. 30, Iss. 10, pp. 943-950
Open Access | Times Cited: 2
Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM
Wenjing Zhang, Jiexiu Chen, Juan Bi, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 6
Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects
Yuichiro Iwamoto, Tomohiko Kimura, Kazunori Dan, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group
Maria Chiara Zatelli, Antongiulio Faggiano, Antonella Argentiero, et al.
Cancer Treatment Reviews (2024) Vol. 126, pp. 102734-102734
Open Access | Times Cited: 1
Pediatric thyroid side effects of immune checkpoint inhibitors
Cesare Morgante, Alessandra Fierabracci, Armando Grossi
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 9, pp. 765-768
Closed Access | Times Cited: 1
Cardiotoxicity associated with immune checkpoint inhibitors: Systematic Review and Meta-analysis
L Piazza, Anna Carollo, E Di Martino, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104587-104587
Closed Access | Times Cited: 1
Immunotherapy as a Turning Point in the Treatment of Melanoma Brain Metastases
Gil Nuno Castro Fernandes
Discoveries (2023) Vol. 11, Iss. 2, pp. e169-e169
Open Access | Times Cited: 3
Research Advances of Immune Checkpoint Inhibitors Related Endocrine Adverse Events
晶晶 王
Advances in Clinical Medicine (2024) Vol. 14, Iss. 02, pp. 2706-2716
Closed Access
Update on Neuro-ophthalmic Manifestations of Immune Checkpoint Inhibitors
Amalie Chen, Bart K. Chwalisz
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 5, pp. 113-122
Closed Access
Immunotherapy-Related Hypothyroidism: Mechanisms and Management
Selin Çakmak Demir, Dilek Yazıcı
IntechOpen eBooks (2024)
Open Access
Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
Salvatore Cortellino, Margherita D’Angelo, Massimiliano Quintiliani, et al.
Journal of Cellular Physiology (2024) Vol. 240, Iss. 1
Closed Access
Prospects and challenges of immunotherapy for thyroid cancer
Ping Song, Gang Pan, Yu Zhang, et al.
Endocrine Practice (2024)
Closed Access
An individualized protein-based prognostic model to stratify pediatric patients with papillary thyroid carcinoma
Zhihong Wang, He Wang, Yan Zhou, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top